Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Outset Medical, Inc. (OM) had Revenue of $28.87M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$28.87M
Net Income	$-19.49M
Cost of Goods Sold	$16.64M
Gross Profit	$12.23M
Operating Expenses	$46.50M
Operating Income	$-17.63M
Non-Operating Income/Expense	$-1.77M
Pre-Tax Income	$-19.40M
Normalized Pre-Tax Income	$-19.40M
Income after Taxes	$-19.49M
Income from Continuous Operations	$-19.49M
Consolidated Net Income/Loss	$-19.49M
Normalized Income after Taxes	$-19.49M
EBIT	$-17.63M
EBITDA	$-17.28M
Weighted-Average Shares Outstanding (Basic)	15.21M
Weighted-Average Shares Outstanding (Diluted)	15.21M
Earnings per Share (EPS) (Basic)	$0.33
Earnings per Share (EPS) (Diluted)	$0.33
Balance Sheet Financials
Current Assets	$250.88M
Property, Plant, and Equipment	$4.67M
Long-Term Assets	$13.61M
Total Assets	$264.50M
Current Liabilities	$37.63M
Long-Term Debt	$96.24M
Long-Term Liabilities	$99.91M
Total Liabilities	$137.54M
Common Equity	$126.95M
Tangible Shareholders Equity	$126.95M
Shareholders Equity	$126.95M
Common Shares Outstanding	18.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-46.33M
Cash Flow from Investing Activities	$-97.68M
Cash Flow from Financial Activities	$55.50M
Beginning Cash	$127.34M
End Cash	$38.84M
Increase/Decrease in Cash	$-88.51M
Stock-Based Compensation	$15.62M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.67
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	0.76
Gross Margin	42.36%
Operating Margin	-61.05%
EBIT Margin	-61.05%
EBITDA Margin	--
Pre-Tax Profit Margin	-67.17%
Profit Margin	-67.50%
Free Cash Flow	$-47.12M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.35
Receiveable Turnover	1.02
Days Sales in Receivables	88.30
Return on Equity	-15.35%
Return on Tangible Equity	-15.35%
Return on Assets	-7.37%
Return on Investments	-8.73%
Book Value Per Share	$6.99
Free Cash Flow per Share	$-3.10
Operating Cash Flow per Share	$-3.05

Data from Zacks Investment Research, Inc.